Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

DPC-Exos can help regenerate hair follicles and heal wounds by activating the Wnt/β-catenin pathway.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

A child with skin and heart issues had rare genetic mutations affecting skin and heart cell cohesion.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

The cooling system effectively and safely treats benign pigmented lesions in Asians.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

PDCD4 is important for controlling skin cell growth and healing.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

DCPA commonly affects males' lower legs, showing follicular pustules and white areas.

Corticosteroids effectively treated a 60-year-old man's skin condition.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Home-use treatment for severe alopecia areata is as effective as office-use but costs half as much.

Noncrosslinked hyaluronic acid helps human hair cells grow and could be a potential hair loss treatment.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.